Softwr

Healthcare · head to head

Paige vs Sectra

Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite
Sectra logo

Sectra

Healthcare

Enterprise imaging and PACS from a Swedish vendor that also sells the pathology and cardiology modules on one platform

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.; Sectra sectra does not make scanners, so it cannot cross-subsidise software against modality hardware the way an integrated manufacturer can, and it often loses on headline price in a bundled tender.
  • They diverge on capability: Paige covers Paige Prostate Detect, Sectra covers Sectra IDS7.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Paige and Sectra actually diverge.

Attributes where Paige and Sectra differ
AttributePaigeSectra
PlatformsWeb, Cloud, On-premiseWindows, Web, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

Only in Sectra

  • Sectra IDS7
  • Digital pathology module
  • Sectra VNA
  • Sectra UniView
  • Image Exchange Portal
  • Sectra Amplifier
  • Breast imaging workflow
  • Sectra One Cloud

What people use each for

The jobs each tool is most often brought in to do.

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Sectra
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Sectra
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Sectra
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Sectra

Sectra

  • A hospital group digitising histopathology that does not want a second image archive and a second integration project alongside radiologynot Paige
  • A regional health service replacing several departmental PACS with one archive and one clinician viewernot Paige
  • An imaging provider moving off a capital refresh cycle to a cloud subscription with predictable annual costnot Paige
  • A trust that needs to send and receive studies with neighbouring organisations routinely, where the Image Exchange Portal is already the regional normnot Paige

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Sectra

  • Sectra does not make scanners, so it cannot cross-subsidise software against modality hardware the way an integrated manufacturer can, and it often loses on headline price in a bundled tender.
  • Diagnostic AI is not built in house; Amplifier orchestrates third party algorithms, so the algorithms themselves need separate licences, separate clinical validation and separate information governance sign off.
  • Sectra One Cloud is priced against a committed annual study volume, and organisations whose imaging activity grows faster than forecast meet overage charges partway through the term.
  • The pathology module assumes you have already solved slide scanning and laboratory workflow, which is the larger and more expensive part of digitising histopathology and is not in Sectra scope.
  • Depth of Epic and Oracle Health integration varies by region and by which modules you buy, so a reference site in Sweden is a weak predictor of what integration will cost a United States buyer.

Pricing, plan by plan

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Sectra

On request
  • Sectra Enterprise Imaging$undefined/year
    • Perpetual licence plus annual maintenance, or Sectra One Cloud subscription
    • Priced on committed annual study volume and modules selected
    • Pathology, cardiology and ophthalmology licensed as separate modules

Which should you pick?

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Choose Sectra if

  • You need sectra ids7.
  • You work on Windows, Web, Cloud, On-premise.
  • You also want digital pathology module.
Sectra review

Questions people ask

Is Paige or Sectra better?
Neither clearly leads. Paige starts at On request and Sectra at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Paige or Sectra?
Paige starts at On request and Sectra at On request.
Does Paige or Sectra run on more platforms?
Paige runs on Web, Cloud, On-premise. Sectra runs on Windows, Web, Cloud, On-premise.
What is Paige best used for?
Paige is most often used for a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable, a pathology department already digitised that wants a documented safety net against missed small foci of cancer, a hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reporting, a pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variability. Of those, a reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffable and a pathology department already digitised that wants a documented safety net against missed small foci of cancer are not what Sectra is typically brought in for.
What can Paige do that Sectra cannot?
Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications. Sectra covers Sectra IDS7, Digital pathology module, Sectra VNA, Sectra UniView.

Answered from the vendors’ own pages

Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Sectra: Does Sectra include diagnostic AI?

No. Sectra Amplifier is a marketplace and orchestration layer for third party algorithms, each licensed and validated separately.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Sectra: Is pathology really on the same platform as radiology?

Yes, the pathology module uses the same archive and workflow engine, which is the main reason buyers digitising histopathology shortlist Sectra.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Sectra: How is Sectra One Cloud priced?

On committed annual study volume plus the modules selected, as a subscription rather than a capital purchase. The vendor does not publish rates.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Sectra: Is Sectra CE marked and FDA cleared?

The diagnostic viewing software carries CE marking under the medical device regulation and FDA 510(k) clearance for diagnostic interpretation, but the exact cleared indications differ per module and per market, so confirm for pathology specifically.

Share

Related pages

More on Paige

More on Sectra

Keep looking

Other head to heads